Shanghai's SARI Pays $359M for Italian Cancer Biopharma NMS Post author:Sam Post published:December 28, 2017 Post category:BioPharma The parts expect the closing in the first quarter 2018. Source: BioSpace You Might Also Like Former Google Exec Steps Down as GRAIL CEO August 2, 2017 Invacare Proposes $100 Million Raise June 8, 2017 FDA Calls BioMarin's Hemophilia A Drug a Breakthrough October 25, 2017
